Pleomorphic Variant Mantle Cell Lymphoma

• CLINICAL_TRIALS research · 2026-02-19
  Clinical Trial Update: Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating a quadruple regimen of glofitamab, obinutuzumab, venetoclax, and lenalidomide for newly diagnosed high…